Artios
Artios Pharma is a clinical‑stage oncology company focused on developing novel DNA Damage Response (DDR) medicines to treat cancer. Founded in 2016 and based in Cambridge, UK, it advances a pipeline including ATR inhibitor alnodesertib, Polθ inhibitor ART6043, and DDRi‑ADC candidate ART21934, aiming to deliver meaningful survival benefits to patients with high unmet need.
Artios is profiled on the APIs.io network. Tagged areas include Pharma, Oncology, DDR, Clinical Stage, and Cambridge.
Artios’ developer surface includes documentation, getting-started guide, support, engineering blog, and 7 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Get Started 1
Portal, sign-up, and the first successful call
Documentation 1
Reference material describing how the API behaves
Design & Contract 1
Pagination, idempotency, versioning, errors, and events
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 3
The organization behind the API
Other 1
Properties that don't map to a standard resource type
Source (apis.yml)
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.